Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cachexia: The last illness.

Literature DB >> 26659165

Cachexia: The last illness.

Corie Lok.

Abstract

Entities: Disease

Mesh：

Year: 2015 PMID： 26659165 DOI： 10.1038/528182a

Source DB: PubMed Journal: Nature ISSN： 0028-0836 Impact factor: 49.962

× No keyword cloud information.

8 in total

1. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival.

Authors: Xiaolan Zhou; Jin Lin Wang; John Lu; Yanping Song; Keith S Kwak; Qingsheng Jiao; Robert Rosenfeld; Qing Chen; Thomas Boone; W Scott Simonet; David L Lacey; Alfred L Goldberg; H Q Han
Journal: Cell Date: 2010-08-20 Impact factor: 41.582

2. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy.

Authors: M D Gomes; S H Lecker; R T Jagoe; A Navon; A L Goldberg
Journal: Proc Natl Acad Sci U S A Date: 2001-11-20 Impact factor: 11.205

3. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial.

Authors: James T Dalton; Kester G Barnette; Casey E Bohl; Michael L Hancock; Domingo Rodriguez; Shontelle T Dodson; Ronald A Morton; Mitchell S Steiner
Journal: J Cachexia Sarcopenia Muscle Date: 2011-08-02 Impact factor: 12.910

4. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia.

Authors: Michele Petruzzelli; Martina Schweiger; Renate Schreiber; Ramon Campos-Olivas; Maria Tsoli; John Allen; Michael Swarbrick; Stefan Rose-John; Mercedes Rincon; Graham Robertson; Rudolf Zechner; Erwin F Wagner
Journal: Cell Metab Date: 2014-07-17 Impact factor: 27.287

5. Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia.

Authors: Serkan Kir; James P White; Sandra Kleiner; Lawrence Kazak; Paul Cohen; Vickie E Baracos; Bruce M Spiegelman
Journal: Nature Date: 2014-07-13 Impact factor: 49.962

Review 6. Cancer cachexia: understanding the molecular basis.

Authors: Josep M Argilés; Sílvia Busquets; Britta Stemmler; Francisco J López-Soriano
Journal: Nat Rev Cancer Date: 2014-10-09 Impact factor: 60.716

7. Identification of ubiquitin ligases required for skeletal muscle atrophy.

Authors: S C Bodine; E Latres; S Baumhueter; V K Lai; L Nunez; B A Clarke; W T Poueymirou; F J Panaro; E Na; K Dharmarajan; Z Q Pan; D M Valenzuela; T M DeChiara; T N Stitt; G D Yancopoulos; D J Glass
Journal: Science Date: 2001-10-25 Impact factor: 47.728

8. PTH/PTHrP Receptor Mediates Cachexia in Models of Kidney Failure and Cancer.

Authors: Serkan Kir; Hirotaka Komaba; Ana P Garcia; Konstantinos P Economopoulos; Wei Liu; Beate Lanske; Richard A Hodin; Bruce M Spiegelman
Journal: Cell Metab Date: 2015-12-06 Impact factor: 27.287

8 in total

26 in total

1. Cachexia: Treat wasting illness on multiple fronts.

Authors: Kenneth Fearon
Journal: Nature Date: 2016-01-14 Impact factor: 49.962

2. Multi-omics Analysis of Serum Samples Demonstrates Reprogramming of Organ Functions Via Systemic Calcium Mobilization and Platelet Activation in Metastatic Melanoma.

Authors: Besnik Muqaku; Martin Eisinger; Samuel M Meier; Ammar Tahir; Tobias Pukrop; Sebastian Haferkamp; Astrid Slany; Albrecht Reichle; Christopher Gerner
Journal: Mol Cell Proteomics Date: 2016-11-22 Impact factor: 5.911

Review 3. Sarcopenia in gastric cancer: when the loss costs too much.

Authors: Elena Ongaro; Vanessa Buoro; Marika Cinausero; Riccardo Caccialanza; Annalisa Turri; Valentina Fanotto; Debora Basile; Maria Grazia Vitale; Paola Ermacora; Giovanni Gerardo Cardellino; Laura Nicoletti; Lorenzo Fornaro; Andrea Casadei-Gardini; Giuseppe Aprile
Journal: Gastric Cancer Date: 2017-05-05 Impact factor: 7.370

4. CRISPR-Cas9-induced IGF1 gene activation as a tool for enhancing muscle differentiation via multiple isoform expression.

Authors: Matthew J Roberston; Suchi Raghunathan; Vladimir N Potaman; Fan Zhang; M David Stewart; Bradley K McConnell; Robert J Schwartz
Journal: FASEB J Date: 2019-11-25 Impact factor: 5.191

Cachexia: The last illness.

1. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival.

2. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy.

3. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial.

4. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia.

5. Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia.

Review 6. Cancer cachexia: understanding the molecular basis.

7. Identification of ubiquitin ligases required for skeletal muscle atrophy.

8. PTH/PTHrP Receptor Mediates Cachexia in Models of Kidney Failure and Cancer.

1. Cachexia: Treat wasting illness on multiple fronts.

2. Multi-omics Analysis of Serum Samples Demonstrates Reprogramming of Organ Functions Via Systemic Calcium Mobilization and Platelet Activation in Metastatic Melanoma.

Review 3. Sarcopenia in gastric cancer: when the loss costs too much.

4. CRISPR-Cas9-induced IGF1 gene activation as a tool for enhancing muscle differentiation via multiple isoform expression.

Review 5. Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment.

6. Molecular and Physiological Evaluation of Pancreatic Cancer-Induced Cachexia.

7. A Novel Non-Peptidic Agonist of the Ghrelin Receptor with Orexigenic Activity In vivo.

8. Cachexia: looking yet not seeing.

9. Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release.

Review 10. Mechanisms of metabolic dysfunction in cancer-associated cachexia.